Net Sales increased 0.2%, or 0.1%
Organic
Significant Gross Margin Expansion
GAAP EPS increased 95%, Adjusted EPS increased 57%
Updates Full Year Outlook
SHELTON,
Conn., May 8, 2024 /PRNewswire/ -- Edgewell
Personal Care Company (NYSE: EPC) today announced results for its
second fiscal quarter 2024 ended March 31,
2024.
Executive Summary
- Net sales were $599.4 million, an
increase of 0.2% compared to the prior year quarter.
- Organic net sales increased 0.1% (Organic basis excludes the
impact from currency movements.)
- GAAP Diluted Net Earnings Per Share ("EPS") were $0.72, compared to $0.37 in the prior year quarter.
- Adjusted EPS were $0.88, compared
to $0.56 in the prior year
quarter.
- Ended the second quarter with $196.2
million in cash on hand, access to an additional
$308.7 million revolving credit
facility and a net debt leverage ratio of 3.4x.
- Returned $23.5 million to
shareholders in the form of $15.3
million in share repurchases and $8.2
million of dividends in the second quarter.
- The Board of Directors declared a cash dividend of $0.15 per common share on May 8, 2024 for the second quarter.
The Company reports and forecasts results on a GAAP and
non-GAAP basis and has reconciled non-GAAP results and outlook to
the most directly comparable GAAP measures later in this release.
See non-GAAP Financial Measures for a more detailed explanation,
including definitions of various non-GAAP terms used in this
release. All comparisons used in this release are for the
same period in the prior fiscal year unless otherwise
stated.
"In a challenging and somewhat volatile operating environment,
our second quarter results reflect strong gross margin expansion
that fueled significant adjusted EBITDA and earnings per share
growth. Organic net sales growth included a double-digit
increase in our Right-to-Win portfolio, driven by our
market-leading Sun Care and Grooming
businesses. Our International markets continued to deliver
accelerated growth, with a healthy combination of both price and
volume gains. Importantly, we delivered over 300-basis points
of adjusted gross margin expansion, underpinned by disciplined
execution of both our cost productivity and strategic revenue
management efforts," said Rod
Little, Edgewell's President and Chief Executive
Officer. "Given our first half performance, we now expect to
deliver full year sales at the lower end of our outlook range, and
we are raising our outlook for adjusted EPS and EBITDA. Our
strategy continues to generate positive results and gives us
confidence in our ability to generate long-term value for our
shareholders."
Fiscal 2Q 2024 Operating Results (Unaudited)
Net sales were $599.4
million in the quarter, an increase of 0.2%, including a
$0.3 million favorable impact from
currency movements. Organic net sales increased 0.1%, as strong
performance in International markets and double-digit global growth
in Sun Care and Grooming were mostly
offset by declines in North America Wet Shave and Feminine Care. In
aggregate, increased pricing and revenue management as well as
higher volumes in International markets were largely offset by
lower volumes in North
America.
Gross profit was $258.1
million, as compared to $242.3
million in the prior year quarter. Gross margin as a
percent of net sales increased 260-basis points, to 43.1% in the
quarter. Adjusted gross margin, as a percent of net sales,
increased 320-basis points, as productivity savings of
approximately 240-basis points and the benefit of higher pricing
and strategic revenue management of approximately 190-basis points,
more than offset core gross inflationary pressures of approximately
60-basis points, unfavorable mix and other costs of 40-basis
points, and a 10-basis point unfavorable impact from currency.
Advertising and sales promotion expense
("A&P") was $63.1
million, or 10.5% of net sales, an increase of $0.2 million, compared to $62.9 million, or 10.5%, of net sales in the
prior year quarter.
Selling, general and administrative expense
("SG&A") was $107.5
million, or 17.9% of net sales, as compared to $105.2 million, or 17.6% of net sales in the
prior year quarter. Adjusted SG&A as a percent of net sales
increased 20-basis points, primarily driven by higher people
expenses, partially offset by operational efficiency savings and
lower bad debt and other corporate costs.
The Company recorded pre-tax restructuring and re-positioning
expenses, consisting largely of severance and related costs in
support of cost efficiency programs, of $3.2
million in the quarter, a charge related to a legal matter
of $1.4 million, acquisition and
integration costs related to the Billie acquisition of $0.7 million, and other projects cost of
$1.1 million.
Operating income, was $70.1
million, inclusive of a $0.7
million unfavorable impact from currency movements, compared
to $56.8 million in the prior year
quarter. Adjusted operating income was $80.7
million, or 13.5% of net sales, compared to $63.1 million, or 10.5% of net sales in the prior
year quarter. Adjusted operating margin increased 300-basis points,
reflecting higher gross margin, partly offset by higher A&P and
SG&A expenses.
Interest expense associated with debt was
$20.4 million, compared to
$20.7 million in the prior year
quarter. The decrease in interest expense was the result of a lower
overall debt balance on the Company's revolving credit facility,
partially offset by higher interest rates.
Other expense, net was $2.7
million compared to $9.5
million in the prior year quarter. The prior year quarter
included a $7.2 million charge for
the wind-up of the Company's Canadian defined benefit
plan.
The effective tax rate for the first six months of
fiscal 2024 was 23.0% compared to 26.9% in the prior year
period. The adjusted effective tax rate for the first six
months of fiscal 2024 was 23.5%, down from the prior year period
adjusted effective tax rate of 26.5%. The fiscal 2024
effective tax rate reflects the favorable mix of earnings in lower
tax rate jurisdictions and the impact of a change in the Company's
prior estimates.
GAAP net earnings were $36.0
million or $0.72 per diluted
share compared to $19.4 million or
$0.37 per diluted share in the prior
year quarter. Adjusted net earnings were $44.0 million or $0.88 per share, inclusive of a $0.02 unfavorable currency impact, compared to
$29.4 million or $0.56 per share in the prior year quarter.
Adjusted EBITDA was $99.7 million,
inclusive of a $1.3 million
unfavorable currency impact, compared to $83.6 million in the prior year
quarter.
Net cash provided by operating activities was
$56.1 million for the six months
ending March 31, 2024, compared to $1.9
million in the prior year period. The increase in cash
provided by operating activities was largely driven by lower net
working capital build and increased earnings.
Capital Allocation
On May 8, 2024, the Board of
Directors declared a quarterly cash dividend of $0.15 per common share for the second fiscal
quarter of fiscal 2024. The dividend will be payable on
July 9, 2024, to shareholders of
record as of the close of business on June
6, 2024. During the second quarter of fiscal 2024, the
Company paid dividends totaling $8.2
million to stockholders.
During the second quarter of fiscal 2024, the Company completed
share repurchases of approximately 0.4 million shares at a total
cost of $15.3 million. As of
March 31, 2024, the Company had 3.8 million shares of
common stock available for repurchase in the future under the
Board's 2018 authorization.
Fiscal 2Q 2024 Operating Segment Results (Unaudited)
Wet Shave (Men's Systems, Women's Systems, Disposables,
and Shave Preps)
Net sales decreased $15.5 million,
or 5.0%. Organic net sales decreased $13.9
million or 4.5%, as growth in international markets, driven
by higher volumes and price, was more than offset by declines in
North America. North America sales were impacted by weakening
category and channel dynamics, particularly in the highly
promotional drug channel, the impact of cycling the pipeline fill
of a new product introduction, primarily in the club channel, and
changes in the promotional calendar. Wet Shave segment profit
increased $5.0 million, or 14.1%.
Organic segment profit, excluding the unfavorable impact from
currency increased $6.8 million, or
19.2%, reflecting higher gross margins.
Sun and Skin Care (Sun
Care, Wet Ones, Bulldog, Jack
Black and Cremo)
Net sales increased $26.1 million,
or 12.4%. Organic net sales increased $24.2
million, or 11.5%, driven by double-digit Sun Care growth across both North
America and International markets, as well as double-digit
growth in North America Grooming. Sun
Care growth reflects strong early-season execution in the
U.S., Mexico and Europe, while Grooming results were driven by
strong Cremo and Bull Dog sales, and the initial launch of the
Billie brand into women's grooming. Sun and Skin segment profit
increased $14.4 million. Organic
segment profit increased $13.3
million, or 33.2%, primarily driven by higher gross margins,
partly offset by higher marketing and SG&A expenses.
Feminine Care (Tampons, Pads, and Liners)
Net sales decreased $9.6 million,
or 12.0% with minimal currency impact, largely driven by a decline
in Tampons and Pads, partly offset by growth in Liners. Segment
profit decreased $3.5 million, or
28.7%. Organic segment profit decreased $3.5
million, or 28.7%, primarily driven by lower sales and the
resulting impact on gross profit.
Full Fiscal Year 2024 Financial Outlook
The Company is providing the following outlook assumptions for
fiscal 2024:
- Organic net sales are now expected to increase at the lower end
of the previous range of 2% to 4%
- Currency is not expected to impact reported results
(previously, an estimated 60-basis point negative impact)
- GAAP EPS is unchanged and expected to be in the range of
$2.20 to $2.40
- Includes: Restructuring and re-positioning charges*,
Acquisition and integration costs, Sun
Care reformulation, costs related to the Wet One's
manufacturing plant fire, a Legal matter charge, and Other
costs
- Adjusted EPS is now expected to be in the range of $2.80 to $3.00
(previously in the range of $2.65 to
$2.85)
- Includes an estimated $0.17 EPS
unfavorable impact from foreign currency movements (previously
$0.20 EPS unfavorable impact)
- Adjusted gross margin is now expected to increase approximately
120-basis points to the prior year (previously 80-basis
points)
- The EPS outlook reflects the impact of share repurchases of
approximately $50 million
- Adjusted EBITDA is now expected to be in the range of
$348 to $360
million (previously, in the range of $340 to $352
million
- Includes an estimated $11 million
unfavorable impact from foreign currency changes (previously
$14 million unfavorable impact)
- Other Expense, net is expected to be approximately $3 million
- Interest expense associated with debt is expected to be
approximately $78 million
- Adjusted effective tax rate is expected to be approximately
22%
- Total depreciation and amortization expense expected to be
approximately $92 million
(previously, $93 million)
- Capital expenditures expected to be approximately 2.5% to 3.0%
of net sales
- Free cash flow is expected to be approximately $170 million
* In fiscal 2024, the Company is taking specific
actions to strengthen its operating model, simplify the
organization and improve manufacturing and supply chain efficiency
through restructuring and re-positioning actions. As a result of
these actions, the Company expects to incur pre-tax charges of
approximately $19 million for the
full fiscal year.
Webcast Information
In conjunction with this announcement, the Company will hold an
investor conference call beginning at 8:00
a.m. Eastern Time today. All interested parties may access a
live webcast of this conference call at www.edgewell.com, under the
"Investors," and "News and Events" tabs or by using the following
link: http://ir.edgewell.com/news-and-events/events
For those unable to participate during the live webcast, a
re-play will be available on www.edgewell.com, under the
"Investors," "Financial Reports," and "Quarterly Earnings"
tabs. This release includes references to the Company's
website and references to additional information and materials
found on its website. The Company's website and such information
and materials are not incorporated by reference in, and are not
part of, this release.
About Edgewell
Edgewell is a leading pure-play consumer products company with
an attractive, diversified portfolio of established brand names
such as Schick®, Wilkinson Sword® and Billie® men's and women's
shaving systems and disposable razors; Edge and Skintimate® shave
preparations; Playtex®, Stayfree®, Carefree® and o.b.® feminine
care products; Banana Boat®, Hawaiian Tropic®, Bulldog®, Jack
Black®, and CREMO® sun and skin care products; and Wet Ones®
products. The Company has a broad global footprint and operates in
more than 50 markets, including the U.S., Canada, Mexico, Germany, Japan, the U.K. and Australia, with approximately 6,800 employees
worldwide.
Forward-Looking Statements. This document contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. You should not place undue reliance on these
statements. Forward-looking statements generally can be identified
by the use of words or phrases such as "believe," "expect,"
"expectation," "anticipate," "may," "could," "intend," "belief,"
"estimate," "plan," "target," "predict," "likely," "will,"
"should," "forecast," "outlook," or other similar words or phrases.
These statements are not based on historical facts, but instead
reflect the Company's expectations, estimates or projections
concerning future results or events, including, without limitation,
the future earnings and performance of Edgewell or any of its
businesses. Many factors outside our control could affect the
realization of these estimates. These statements are not guarantees
of performance and are inherently subject to known and unknown
risks, uncertainties and assumptions that are difficult to predict
and could cause the Company's actual results to differ materially
from those indicated by those statements. The Company cannot assure
you that any of its expectations, estimates or projections will be
achieved. The forward-looking statements included in this document
are only made as of the date of this document and the Company
disclaims any obligation to publicly update any forward-looking
statement to reflect subsequent events or circumstances, except as
required by law. You should not place undue reliance on these
statements.
In addition, other risks and uncertainties not presently known
to the Company or that it presently considers immaterial could
significantly affect the accuracy of any such forward-looking
statements. Risks and uncertainties include those detailed from
time to time in the Company's publicly filed documents, including
in Item 1A. Risk Factors of Part I of the Company's Annual Report
on Form 10-K filed with the Securities and Exchange Commission on
November 28, 2023.
Non-GAAP Financial Measures. While the Company reports
financial results in accordance with generally accepted accounting
principles ("GAAP") in the U.S., this discussion also includes
non-GAAP measures. These non-GAAP measures are referred to as
"adjusted" or "organic" and exclude items which are considered by
the Company as unusual or non-recurring and which
may have a disproportionate positive or negative impact on the
Company's financial results in any particular period.
Reconciliations of non-GAAP measures, including reconciliations of
measures related to the Company's fiscal 2024 financial outlook,
are included within the Notes to Condensed Consolidated Financial
Statements included with this release.
This non-GAAP information is provided as a supplement to, not as
a substitute for, or as superior to, measures of financial
performance prepared in accordance with GAAP. The Company uses this
non-GAAP information internally to make operating decisions and
believes it is helpful to investors because it allows more
meaningful period-to-period comparisons of ongoing operating
results. The information can also be used to perform analysis and
to better identify operating trends that may otherwise be masked or
distorted by the types of items that are excluded. This non-GAAP
information is a component in determining management's incentive
compensation. Finally, the Company believes this information
provides a higher degree of transparency. The following provides
additional detail on the Company's non-GAAP measures:
- The Company utilizes "adjusted" non-GAAP measures including
gross profit, SG&A, operating income, income taxes, net
earnings, diluted earnings per share, and EBITDA to internally make
operating decisions.
- Constant currency measures are calculated by removing the
impact of translational and transactional foreign currencies
changes, net of foreign currency hedges compared to the prior year.
Transactional foreign currency changes are driven by foreign legal
entities' transactions not denominated in local currency.
- The Company analyzes its net sales and segment profit on an
organic basis to better measure the comparability of results
between periods. Organic net sales and organic segment profit
exclude the impact of changes in foreign currency and the impact of
acquisitions.
- Segment profit will be impacted by fluctuations in translation
and transactional foreign currency. The impact of currency was
applied to segments using management's best estimate.
- Free cash flow is defined as net cash from operating
activities, less capital expenditures plus collections of deferred
purchase price of accounts receivable sold and proceeds from sales
of fixed assets. Free cash flow conversion is defined as free cash
flow as a percentage of net earnings adjusted for the net impact of
non-cash impairments.
- Net debt is defined as gross debt less cash. Net debt leverage
ratio is defined as net debt less cash divided by trailing twelve
month adjusted EBITDA.
Basis of Presentation. Please refer to the Annual
Report on Form 10-K filed with the Securities and Exchange
Commission on November 28, 2023, for
a revision of previously issued consolidated financial statements,
which may impact year over year results or future estimates
included in this release.
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED STATEMENTS OF EARNINGS
(unaudited, in
millions, except per share data)
|
|
|
Three Months
Ended
March
31,
|
|
Six Months
Ended
March
31,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net sales
|
$
599.4
|
|
$
598.4
|
|
$
1,088.3
|
|
$
1,067.5
|
Cost of products
sold
|
341.3
|
|
356.1
|
|
632.5
|
|
635.6
|
Gross
profit
|
258.1
|
|
242.3
|
|
455.8
|
|
431.9
|
|
|
|
|
|
|
|
|
Selling, general and
administrative expense
|
107.5
|
|
105.2
|
|
210.8
|
|
200.9
|
Advertising and sales
promotion expense
|
63.1
|
|
62.9
|
|
111.3
|
|
108.8
|
Research and
development expense
|
14.2
|
|
14.4
|
|
27.5
|
|
27.8
|
Restructuring
charges
|
3.2
|
|
3.0
|
|
10.0
|
|
5.7
|
Operating
income
|
70.1
|
|
56.8
|
|
96.2
|
|
88.7
|
Interest expense
associated with debt
|
20.4
|
|
20.7
|
|
40.2
|
|
40.6
|
Other expense,
net
|
2.7
|
|
9.5
|
|
3.0
|
|
4.5
|
Earnings before
income taxes
|
47.0
|
|
26.6
|
|
53.0
|
|
43.6
|
Income tax
provision
|
11.0
|
|
7.2
|
|
12.2
|
|
11.8
|
Net
earnings
|
$
36.0
|
|
$
19.4
|
|
$
40.8
|
|
$
31.8
|
|
|
|
|
|
|
|
|
Earnings per
share:
|
|
|
|
|
|
|
|
Basic net earnings per share
|
$
0.72
|
|
$
0.38
|
|
$
0.82
|
|
$
0.62
|
Diluted net earnings per share
|
$
0.72
|
|
$
0.37
|
|
$
0.81
|
|
$
0.61
|
|
|
|
|
|
|
|
|
Weighted-average
shares outstanding:
|
|
|
|
|
|
|
|
Basic
|
49.8
|
|
51.4
|
|
50.0
|
|
51.5
|
Diluted
|
50.2
|
|
52.0
|
|
50.3
|
|
52.0
|
|
|
|
|
|
|
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED BALANCE SHEETS
(unaudited, in
millions)
|
|
|
March 31,
2024
|
|
September
30,
2023
|
Assets
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
196.2
|
|
$
216.4
|
Trade receivables,
less allowance for doubtful accounts
|
130.6
|
|
106.2
|
Inventories
|
496.4
|
|
492.4
|
Other current
assets
|
171.6
|
|
147.4
|
Total current
assets
|
994.8
|
|
962.4
|
Property, plant and
equipment, net
|
327.5
|
|
337.9
|
Goodwill
|
1,333.9
|
|
1,331.4
|
Other intangible
assets, net
|
960.4
|
|
973.8
|
Other assets
|
139.7
|
|
135.2
|
Total
assets
|
$
3,756.3
|
|
$
3,740.7
|
|
|
|
|
Liabilities and
Shareholders' Equity
|
|
|
|
Current
liabilities
|
|
|
|
Notes
payable
|
$
23.6
|
|
$
19.5
|
Accounts
payable
|
219.7
|
|
194.4
|
Other current
liabilities
|
298.6
|
|
309.5
|
Total current
liabilities
|
541.9
|
|
523.4
|
Long-term
debt
|
1,350.8
|
|
1,360.7
|
Deferred income tax
liabilities
|
136.1
|
|
136.4
|
Other
liabilities
|
176.2
|
|
179.7
|
Total
liabilities
|
2,205.0
|
|
2,200.2
|
Shareholders'
equity
|
|
|
|
Common
shares
|
0.7
|
|
0.7
|
Additional paid-in
capital
|
1,574.3
|
|
1,593.8
|
Retained
earnings
|
1,047.7
|
|
1,022.1
|
Common shares in
treasury at cost
|
(911.1)
|
|
(906.1)
|
Accumulated other
comprehensive loss
|
(160.3)
|
|
(170.0)
|
Total shareholders'
equity
|
1,551.3
|
|
1,540.5
|
Total liabilities
and shareholders' equity
|
$
3,756.3
|
|
$
3,740.7
|
|
|
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in
millions)
|
|
|
Six Months
Ended
March 31,
|
|
2024
|
|
2023
|
Cash Flow from
Operating Activities
|
|
|
|
Net
earnings
|
$
40.8
|
|
$
31.8
|
Depreciation and
amortization
|
44.9
|
|
45.6
|
Share-based
compensation expense
|
13.3
|
|
13.3
|
Loss on sale of
assets
|
0.2
|
|
1.0
|
Defined benefit
settlement loss
|
—
|
|
7.2
|
Deferred compensation
payments
|
(1.4)
|
|
(4.7)
|
Deferred income
taxes
|
(0.6)
|
|
(0.9)
|
Other, net
|
(5.0)
|
|
(19.4)
|
Changes in current
assets and liabilities used in operations
|
(36.1)
|
|
(72.0)
|
Net cash provided by
operating activities
|
$
56.1
|
|
$
1.9
|
|
|
|
|
Cash Flow from
Investing Activities
|
|
|
|
Capital
expenditures
|
$
(18.0)
|
|
$
(18.8)
|
Collection of deferred
purchase price on accounts receivable sold
|
0.1
|
|
0.8
|
Other, net
|
(1.8)
|
|
(2.0)
|
Net cash used by
investing activities
|
$
(19.7)
|
|
$
(20.0)
|
|
|
|
|
Cash Flow from
Financing Activities
|
|
|
|
Cash proceeds from
debt with original maturities greater than 90 days
|
$
385.0
|
|
$
413.0
|
Cash payments on debt
with original maturities greater than 90 days
|
(396.0)
|
|
(392.0)
|
Proceeds from
(payments for) debt with original maturities of 90 days or
less
|
3.9
|
|
(1.4)
|
Repurchase of
shares
|
(30.3)
|
|
(30.0)
|
Dividends to common
shareholders
|
(15.8)
|
|
(16.1)
|
Net financing inflow
from the Accounts Receivable Facility
|
1.4
|
|
4.8
|
Employee shares
withheld for taxes
|
(7.0)
|
|
(8.1)
|
Other, net
|
(0.6)
|
|
0.8
|
Net cash used by
financing activities
|
$
(59.4)
|
|
$
(29.0)
|
|
|
|
|
Effect of exchange rate
changes on cash
|
2.8
|
|
13.6
|
|
|
|
|
Net decrease in cash
and cash equivalents
|
(20.2)
|
|
(33.5)
|
Cash and cash
equivalents, beginning of period
|
216.4
|
|
188.7
|
Cash and cash
equivalents, end of period
|
$
196.2
|
|
$
155.2
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL CARE COMPANY
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited,
in millions, except per share data)
Note 1 — Segments
The Company conducts its business in the following three
segments: Wet Shave, Sun and Skin Care, and Feminine Care
(collectively, the "Segments," and each individually, a "Segment").
Segment performance is evaluated based on segment profit, exclusive
of general corporate expenses, share-based compensation costs,
items which are considered by the Company to be unusual or
non-recurring and which may have a disproportionate positive or
negative impact on the Company's financial results in any
particular period and the amortization of intangible assets.
Financial items, such as interest income and expense, are managed
on a global basis at the corporate level. The exclusion of such
charges from segment results reflects management's view on how it
evaluates segment performance.
Segment net sales and profitability are presented below:
|
Three Months
Ended
March 31,
|
|
Six Months
Ended
March 31,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net
Sales
|
|
|
|
|
|
|
|
Wet Shave
|
$
293.1
|
|
$
308.6
|
|
$
594.8
|
|
$
583.9
|
Sun and Skin
Care
|
235.8
|
|
209.7
|
|
351.2
|
|
322.6
|
Feminine
Care
|
70.5
|
|
80.1
|
|
142.3
|
|
161.0
|
Total net
sales
|
$
599.4
|
|
$
598.4
|
|
$
1,088.3
|
|
$
1,067.5
|
|
|
|
|
|
|
|
|
Segment
Profit
|
|
|
|
|
|
|
|
Wet Shave
|
$
40.4
|
|
$
35.4
|
|
$
94.1
|
|
$
71.1
|
Sun and Skin
Care
|
54.4
|
|
40.0
|
|
53.1
|
|
53.3
|
Feminine
Care
|
8.7
|
|
12.2
|
|
16.0
|
|
24.1
|
Total segment
profit
|
103.5
|
|
87.6
|
|
163.2
|
|
148.5
|
General corporate and
other expenses
|
(15.0)
|
|
(17.0)
|
|
(31.2)
|
|
(32.9)
|
Amortization of
intangibles
|
(7.8)
|
|
(7.7)
|
|
(15.6)
|
|
(15.4)
|
Interest and other
expense, net
|
(23.1)
|
|
(23.0)
|
|
(43.2)
|
|
(37.9)
|
Restructuring and
repositioning expenses
|
(3.2)
|
|
(3.0)
|
|
(10.0)
|
|
(5.8)
|
Acquisition and
integration costs
|
(0.7)
|
|
(2.0)
|
|
(1.4)
|
|
(4.1)
|
Sun Care reformulation
costs
|
(0.4)
|
|
(0.6)
|
|
(0.9)
|
|
(1.1)
|
Wet Ones manufacturing
plant fire
|
(3.8)
|
|
—
|
|
(5.3)
|
|
—
|
Legal
matter
|
(1.4)
|
|
—
|
|
(1.4)
|
|
—
|
Defined benefit
settlement loss
|
—
|
|
(7.2)
|
|
—
|
|
(7.2)
|
Other project
costs
|
(1.1)
|
|
(0.5)
|
|
(1.2)
|
|
(0.5)
|
Total earnings
before income taxes
|
$
47.0
|
|
$
26.6
|
|
$
53.0
|
|
$
43.6
|
Refer to Note 2 - GAAP to Non-GAAP Reconciliations for the
income statement location of non-GAAP adjustments to earnings
before income taxes.
Note 2 — GAAP to Non-GAAP Reconciliations
The following tables provide a GAAP to Non-GAAP reconciliation
of certain line items from the Condensed Consolidated Statement of
Earnings:
|
Three Months Ended
March 31, 2024
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 258.1
|
|
$ 107.5
|
|
$ 70.1
|
|
$
47.0
|
|
$
11.0
|
|
$ 36.0
|
|
$
0.72
|
Restructuring and
repositioning expenses
|
—
|
|
—
|
|
3.2
|
|
3.2
|
|
0.8
|
|
2.4
|
|
0.05
|
Acquisition and
integration costs
|
—
|
|
0.7
|
|
0.7
|
|
0.7
|
|
0.1
|
|
0.6
|
|
0.01
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
0.4
|
|
0.4
|
|
0.1
|
|
0.3
|
|
0.01
|
Wet Ones manufacturing
plant fire
|
3.8
|
|
—
|
|
3.8
|
|
3.8
|
|
0.9
|
|
2.9
|
|
0.06
|
Legal
matter
|
—
|
|
1.4
|
|
1.4
|
|
1.4
|
|
0.3
|
|
1.1
|
|
0.02
|
Other project
costs
|
—
|
|
1.1
|
|
1.1
|
|
1.1
|
|
0.4
|
|
0.7
|
|
0.01
|
Total Adjusted
Non-GAAP
|
$ 261.9
|
|
$ 104.3
|
|
$ 80.7
|
|
$
57.6
|
|
$
13.6
|
|
$ 44.0
|
|
$
0.88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Non-GAAP
Constant Currency
|
|
$
0.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
43.1 %
|
|
17.9 %
|
|
11.7 %
|
|
GAAP effective tax
rate
|
23.4 %
|
|
|
Adjusted as a percent
of net sales
|
43.7 %
|
|
17.4 %
|
|
13.5 %
|
|
Adjusted effective tax
rate
|
23.6 %
|
|
|
Adjusted Constant
Currency as a percent of net sales
|
43.8 %
|
|
|
|
13.6 %
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, 2023
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 242.3
|
|
$ 105.2
|
|
$ 56.8
|
|
$
26.6
|
|
$
7.2
|
|
$ 19.4
|
|
$
0.37
|
Restructuring and
repositioning expenses
|
0.2
|
|
—
|
|
3.2
|
|
3.2
|
|
0.9
|
|
2.3
|
|
0.04
|
Acquisition and
integration costs
|
—
|
|
2.0
|
|
2.0
|
|
2.0
|
|
0.5
|
|
1.5
|
|
0.03
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
0.6
|
|
0.6
|
|
0.1
|
|
0.5
|
|
0.01
|
Defined benefit
settlement loss
|
—
|
|
—
|
|
—
|
|
7.2
|
|
1.9
|
|
5.3
|
|
0.10
|
Other costs
|
—
|
|
0.5
|
|
0.5
|
|
0.5
|
|
0.1
|
|
0.4
|
|
0.01
|
Total Adjusted
Non-GAAP
|
$ 242.5
|
|
$ 102.7
|
|
$ 63.1
|
|
$
40.1
|
|
$
10.7
|
|
$ 29.4
|
|
$
0.56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
40.5 %
|
|
17.6 %
|
|
9.5 %
|
|
GAAP effective tax
rate
|
27.0 %
|
|
|
Adjusted as a percent
of net sales
|
40.5 %
|
|
17.2 %
|
|
10.5 %
|
|
Adjusted effective tax
rate
|
26.6 %
|
|
|
(1) EBIT is defined as
Earnings before Income taxes.
|
|
|
|
Six Months Ended
March 31, 2024
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 455.8
|
|
$ 210.8
|
|
$ 96.2
|
|
$
53.0
|
|
$
12.2
|
|
$ 40.8
|
|
$
0.81
|
Restructuring and
repositioning expenses
|
—
|
|
—
|
|
10.0
|
|
10.0
|
|
2.5
|
|
7.5
|
|
0.15
|
Acquisition and
integration costs
|
—
|
|
1.4
|
|
1.4
|
|
1.4
|
|
0.3
|
|
1.1
|
|
0.02
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
0.9
|
|
0.9
|
|
0.2
|
|
0.7
|
|
0.01
|
Wet Ones manufacturing
plant fire
|
5.3
|
|
—
|
|
5.3
|
|
5.3
|
|
1.3
|
|
4.0
|
|
0.08
|
Legal
matter
|
—
|
|
1.4
|
|
1.4
|
|
1.4
|
|
0.3
|
|
1.1
|
|
0.02
|
Other project
costs
|
—
|
|
1.2
|
|
1.2
|
|
1.2
|
|
0.4
|
|
0.8
|
|
0.02
|
Total Adjusted
Non-GAAP
|
$ 461.1
|
|
$ 206.8
|
|
$ 116.4
|
|
$
73.2
|
|
$
17.2
|
|
$ 56.0
|
|
$
1.11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Non-GAAP
Constant Currency
|
|
$
1.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
41.9 %
|
|
19.4 %
|
|
8.8 %
|
|
GAAP effective tax
rate
|
23.0 %
|
|
|
Adjusted as a percent
of net sales
|
42.4 %
|
|
19.0 %
|
|
10.7 %
|
|
Adjusted effective tax
rate
|
23.5 %
|
|
|
Adjusted Constant
Currency as a percent of net sales
|
42.1 %
|
|
|
|
10.4 %
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
March 31, 2023
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 431.9
|
|
$ 200.9
|
|
$ 88.7
|
|
$
43.6
|
|
$
11.8
|
|
$ 31.8
|
|
$
0.61
|
Restructuring and
repositioning expenses
|
0.2
|
|
0.1
|
|
6.0
|
|
6.0
|
|
1.6
|
|
4.4
|
|
0.08
|
Acquisition and
integration costs
|
—
|
|
4.1
|
|
4.1
|
|
4.1
|
|
1.0
|
|
3.1
|
|
0.06
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
1.1
|
|
1.1
|
|
0.2
|
|
0.9
|
|
0.02
|
Defined benefit
settlement loss
|
—
|
|
—
|
|
—
|
|
7.2
|
|
1.9
|
|
5.3
|
|
0.10
|
Other Costs
|
—
|
|
0.5
|
|
0.5
|
|
0.5
|
|
0.1
|
|
0.4
|
|
0.01
|
Total Adjusted
Non-GAAP
|
$ 432.1
|
|
$ 196.2
|
|
$ 100.4
|
|
$
62.5
|
|
$
16.6
|
|
$ 45.9
|
|
$
0.88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
40.5 %
|
|
18.8 %
|
|
8.3 %
|
|
GAAP effective tax
rate
|
26.9 %
|
|
|
Adjusted as a percent
of net sales
|
40.5 %
|
|
18.4 %
|
|
9.4 %
|
|
Adjusted effective tax
rate
|
26.5 %
|
|
|
(1) EBIT is defined as
Earnings before Income taxes.
|
Note 3 - Net Sales and Profit by Segment
Operations for the Company are reported via three Segments. The
following tables present changes in net sales and segment profit
for the three months ended March 31,
2024, as compared to the corresponding period in the prior
year quarter.
Net
Sales
|
Quarter Ended
March 31, 2024
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Net Sales - Q2
2023
|
$
308.6
|
|
|
|
$
209.7
|
|
|
|
$ 80.1
|
|
|
|
$
598.4
|
|
|
Organic
|
(13.9)
|
|
(4.5) %
|
|
24.2
|
|
11.5 %
|
|
(9.6)
|
|
(12.0) %
|
|
0.7
|
|
0.1 %
|
Impact of
currency
|
(1.6)
|
|
(0.5) %
|
|
1.9
|
|
0.9 %
|
|
—
|
|
— %
|
|
0.3
|
|
0.1 %
|
Net Sales - Q2
2024
|
$
293.1
|
|
(5.0) %
|
|
$
235.8
|
|
12.4 %
|
|
$ 70.5
|
|
(12.0) %
|
|
$
599.4
|
|
0.2 %
|
|
|
Net
Sales
|
Six Months
Ended March 31, 2024
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Net Sales - Q2
2023
|
$
583.9
|
|
|
|
$
322.6
|
|
|
|
$
161.0
|
|
|
|
$ 1,067.5
|
|
|
Organic
|
8.5
|
|
1.5 %
|
|
25.2
|
|
7.8 %
|
|
(18.7)
|
|
(11.6) %
|
|
15.0
|
|
1.4 %
|
Impact of
currency
|
2.4
|
|
0.4 %
|
|
3.4
|
|
1.1 %
|
|
—
|
|
— %
|
|
5.8
|
|
0.5 %
|
Net Sales - Q2
2024
|
$
594.8
|
|
1.9 %
|
|
$
351.2
|
|
8.9 %
|
|
$
142.3
|
|
(11.6) %
|
|
$ 1,088.3
|
|
1.9 %
|
|
|
Segment
Profit
|
Quarter Ended
March 31, 2024
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Segment Profit - Q2
2023
|
$ 35.4
|
|
|
|
$ 40.0
|
|
|
|
$ 12.2
|
|
|
|
$ 87.6
|
|
|
Organic
|
6.8
|
|
19.2 %
|
|
13.3
|
|
33.2 %
|
|
(3.5)
|
|
(28.7) %
|
|
16.6
|
|
18.9 %
|
Impact of
currency
|
(1.8)
|
|
(5.1) %
|
|
1.1
|
|
2.8 %
|
|
—
|
|
— %
|
|
(0.7)
|
|
(0.7) %
|
Segment Profit - Q2
2024
|
$ 40.4
|
|
14.1 %
|
|
$ 54.4
|
|
36.0 %
|
|
$ 8.7
|
|
(28.7) %
|
|
$
103.5
|
|
18.2 %
|
|
|
Segment
Profit
|
Six Months
Ended March 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Segment Profit - Q2
2023
|
$ 71.1
|
|
|
|
$ 53.3
|
|
|
|
$ 24.1
|
|
|
|
$
148.5
|
|
|
Organic
|
21.2
|
|
29.8 %
|
|
(1.8)
|
|
(3.4) %
|
|
(8.0)
|
|
(33.2) %
|
|
11.4
|
|
7.7 %
|
Impact of
currency
|
1.8
|
|
2.5 %
|
|
1.6
|
|
3.0 %
|
|
(0.1)
|
|
(0.4) %
|
|
3.3
|
|
2.2 %
|
Segment Profit - Q2
2024
|
$ 94.1
|
|
32.3 %
|
|
$ 53.1
|
|
(0.4) %
|
|
$ 16.0
|
|
(33.6) %
|
|
$
163.2
|
|
9.9 %
|
For all tables, the impact of currency to segment profit
includes both the translational and transactional currency changes
during the quarter.
Note 4 - Net Debt and EBITDA
The Company reports financial results on a GAAP and adjusted
basis. The tables below are used to reconcile Net Debt and Net
earnings to EBITDA and Adjusted EBITDA, which are non-GAAP
measures, to improve comparability of results between periods.
|
|
|
|
|
March 31,
2024
|
|
September
30,
2023
|
Notes
payable
|
|
|
|
|
$
23.6
|
|
$
19.5
|
Long-term
debt
|
|
|
|
|
1,350.8
|
|
1,360.7
|
Gross debt
|
|
|
|
|
$
1,374.4
|
|
$
1,380.2
|
Less: Cash and cash
equivalents
|
|
|
|
|
196.2
|
|
216.4
|
Net Debt
|
|
|
|
|
$
1,178.2
|
|
$
1,163.8
|
|
|
|
Three Months
Ended
March
31,
|
|
Six Months
Ended
March
31,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net
earnings
|
$
36.0
|
|
$
19.4
|
|
$
40.8
|
|
$
31.8
|
Income tax
provision
|
11.0
|
|
7.2
|
|
12.2
|
|
11.8
|
Interest expense,
net
|
19.7
|
|
20.4
|
|
38.8
|
|
40.0
|
Depreciation and
amortization
|
22.4
|
|
23.1
|
|
44.9
|
|
45.6
|
EBITDA
|
$
89.1
|
|
$
70.1
|
|
$
136.7
|
|
$
129.2
|
|
|
|
|
|
|
|
|
Restructuring and
repositioning expenses
|
3.2
|
|
3.2
|
|
10.0
|
|
6.0
|
Acquisition and
integration costs
|
0.7
|
|
2.0
|
|
1.4
|
|
4.1
|
Sun Care reformulation
costs
|
0.4
|
|
0.6
|
|
0.9
|
|
1.1
|
Wet Ones manufacturing
plant fire
|
3.8
|
|
—
|
|
5.3
|
|
—
|
Legal matter
|
1.4
|
|
—
|
|
1.4
|
|
—
|
Defined benefit
settlement loss
|
—
|
|
7.2
|
|
—
|
|
7.2
|
Other project
costs
|
1.1
|
|
0.5
|
|
1.2
|
|
0.5
|
Adjusted
EBITDA
|
$
99.7
|
|
$
83.6
|
|
$
156.9
|
|
$
148.1
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
Constant Currency
|
$
101.0
|
|
|
|
$
158.4
|
|
|
Note 5 - Outlook
The following tables provide reconciliations of Adjusted EPS and
Adjusted EBITDA, Non-GAAP measures, included within the Company's
outlook for projected fiscal 2024 results:
Adjusted EPS
Outlook
|
|
|
Fiscal 2024 GAAP
EPS
|
approx.
|
$2.20 -
$2.40
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
0.38
|
Acquisition and
integration costs
|
approx.
|
0.06
|
Sun Care reformulation
costs
|
approx.
|
0.12
|
Wet Ones manufacturing
plant fire
|
approx.
|
0.13
|
Legal matter
|
approx.
|
0.03
|
Other costs
|
approx.
|
0.07
|
Income
taxes(1)
|
approx.
|
(0.19)
|
|
|
|
Fiscal 2024 Adjusted
EPS Outlook (Non-GAAP)
|
approx.
|
$2.80 -
$3.00
|
(1) Income tax effect of the adjustments to
Fiscal 2024 GAAP EPS noted above.
|
|
|
Adjusted EBITDA
Outlook
|
|
|
Fiscal 2024 GAAP Net
Income
|
approx.
|
$110 - $120
|
Income tax
provision
|
approx.
|
32
|
Interest expense,
net
|
approx.
|
75
|
Depreciation and
amortization
|
approx.
|
92
|
EBITDA
|
approx.
|
$308 - $320
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
19
|
Acquisition and
integration costs
|
approx.
|
3
|
Sun Care reformulation
costs
|
approx.
|
6
|
Wet Ones manufacturing
plant fire
|
approx.
|
6
|
Legal matter
|
approx.
|
2
|
Other project
costs
|
approx.
|
4
|
Fiscal 2024 Adjusted
EBITDA
|
approx.
|
$348 - $360
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-second-quarter-fiscal-2024-results-302138688.html
SOURCE Edgewell Personal Care Company